Amgen Breaks Ground On Next-Generation Biomanufacturing Plant In Rhode Island

The Plant Will be First-of-its-Kind in the U.S. THOUSAND OAKS, Calif., July 31, 2018 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the groundbreaking of its new next-generation biomanufacturing plant that will be constructed at its West Greenwich, R.I. campus. The new plant is the first-of-its-kind in the U.S. and will use Amgen's proven next-generation biomanufacturing capabilities to manufacture products for the U.S. and global markets. "Biologics manufacturing is a complex science and has long been a competitive advantage for Amgen," said Robert A. Bradway, chairman and chief executive officer at Amgen. "We are working to extend that advanta...
Source: Amgen News Release - Category: Pharmaceuticals Tags: Uncategorized Source Type: news